课题基金 / 基金详情

GOG 162 CISPLATIN & PACLITAXEL IN OVARIAN CANCER

GOG 162 CISPLATIN & PACLITAXEL IN OVARIAN CANCER
GOG 162 顺铂
批准号：
6265170
负责人：
STEVEN C PLAXE
金额：
$1.15万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6265170
关键词：
blood chemistry cis platinum compound clinical research combination cancer therapy cytotoxicity drug administration rate /duration drug adverse effect drug screening /evaluation epithelium human mortality human subject human therapy evaluation injection /infusion neoplasm /cancer chemotherapy neoplasm /cancer classification /staging neoplastic process ovary neoplasms paclitaxel

项目摘要

项目成果

STEVEN C PLAXE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Compare the progression-free survival and frequency of response of 24 versus 96 hours paclitaxel influsions combined with cisplatin in stage III and IV epithelial ovarian cancer, determine the incidence and severity of adverse events, and examine the relationship between plasma concentrations and drug toxicity in 24 and 96 hour schedules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ORAL DEXVERAPAMIL AND IV DOXORUBICIN IN OVARIAN CANCER
ACQUISITION OF OVARIAN AND OTHER TISSUE FOR CANCER STUDIES
TAXOL IN REFRACTORY OVARIAN CANCER